Literature DB >> 30540442

Mispacking of the Phe87 Side Chain Reduces the Kinetic Stability of Human Transthyretin.

Xun Sun1, Marcus Jaeger1, Jeffery W Kelly1, H Jane Dyson1, Peter E Wright1.   

Abstract

Aggregation of transthyretin (TTR) causes TTR amyloidoses. The native TTR tetramer (a dimer of dimers) is stabilized by packing of phenylalanine 87 (F87) into a hydrophobic cavity of a neighboring protomer across the strong dimer interface. X-ray structures at acidic pH show that the side chain of F87 can be displaced from its binding pocket, but the resultant solution conformations remain unknown. Here we used 19F nuclear magnetic resonance (NMR) and 19F-labeled C10S-S85C TTR to characterize two local conformations of the loop containing F87. At neutral pH, F87 packs correctly into the interprotomer cavity in the dominant conformational state (93% population, T) whereas the remaining minor population is a mispacked tetramer (T*). The population of T* can be enhanced in heterotetramers by mixing C10S-S85C TTR with increasing molar ratios of A120L TTR, where a bulky leucine residue is introduced to disfavor the T state by steric hindrance. Exchange between the T and T* states in the presence of A120L is mediated by subunit exchange from the C10S-S85C tetramer. Compared to the TTR tetramer in which the dimers are correctly packed, mispacking of one or both dimer pairs leads to an increase in the urea unfolding rate of 4-fold or at least 15-fold, respectively. Consistent acid-mediated tetramer dissociation was observed by 19F NMR aggregation assays. Our results highlight the important role of the interprotomer F87 side chain packing in determining the kinetic stability of the TTR tetramer; mispacking of F87 in the T* state predisposes it for rapid dissociation and entry into the aggregation pathway.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30540442      PMCID: PMC6474804          DOI: 10.1021/acs.biochem.8b01046

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Inhibiting transthyretin conformational changes that lead to amyloid fibril formation.

Authors:  S A Peterson; T Klabunde; H A Lashuel; H Purkey; J C Sacchettini; J W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

Review 2.  The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug.

Authors:  Steven M Johnson; Stephen Connelly; Colleen Fearns; Evan T Powers; Jeffery W Kelly
Journal:  J Mol Biol       Date:  2012-01-05       Impact factor: 5.469

3.  The tetrameric protein transthyretin dissociates to a non-native monomer in solution. A novel model for amyloidogenesis.

Authors:  A Quintas; M J Saraiva; R M Brito
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

4.  Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity.

Authors:  Per Hammarström; Xin Jiang; Amy R Hurshman; Evan T Powers; Jeffery W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-25       Impact factor: 11.205

5.  Transthyretin aggregation under partially denaturing conditions is a downhill polymerization.

Authors:  Amy R Hurshman; Joleen T White; Evan T Powers; Jeffery W Kelly
Journal:  Biochemistry       Date:  2004-06-15       Impact factor: 3.162

6.  Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants.

Authors:  Sean R Miller; Yoshiki Sekijima; Jeffery W Kelly
Journal:  Lab Invest       Date:  2004-05       Impact factor: 5.662

7.  The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.

Authors:  Z Lai; W Colón; J W Kelly
Journal:  Biochemistry       Date:  1996-05-21       Impact factor: 3.162

8.  Tabulation of human transthyretin (TTR) variants, 2003.

Authors:  Lawreen Heller Connors; Amareth Lim; Tatiana Prokaeva; Violet A Roskens; Catherine E Costello
Journal:  Amyloid       Date:  2003-09       Impact factor: 7.141

9.  Fluorotryptophan Incorporation Modulates the Structure and Stability of Transthyretin in a Site-Specific Manner.

Authors:  Xun Sun; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2017-09-28       Impact factor: 3.162

10.  Quantification of transthyretin kinetic stability in human plasma using subunit exchange.

Authors:  Irit Rappley; Cecília Monteiro; Marta Novais; Aleksandra Baranczak; Gregory Solis; R Luke Wiseman; Stephen Helmke; Mathew S Maurer; Teresa Coelho; Evan T Powers; Jeffery W Kelly
Journal:  Biochemistry       Date:  2014-03-24       Impact factor: 3.162

View more
  1 in total

1.  Binding of Monovalent and Bivalent Ligands by Transthyretin Causes Different Short- and Long-Distance Conformational Changes.

Authors:  Alessandra Corazza; Guglielmo Verona; Christopher A Waudby; P Patrizia Mangione; Ryan Bingham; Iain Uings; Diana Canetti; Paola Nocerino; Graham W Taylor; Mark B Pepys; John Christodoulou; Vittorio Bellotti
Journal:  J Med Chem       Date:  2019-08-22       Impact factor: 7.446

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.